The Prognostic Significance of the Histological Types in Patients With Nonsmall Cell Lung Cancer ≤2 cm

Bo Hao; Tao Fan; Juan Xiong; Lin Zhang; Zilong Lu; Bohao Liu; Heng Meng; Ruyuan He; Ning Li; Qing Geng

doi:10.3389/fsurg.2021.721567

The Prognostic Significance of the Histological Types in Patients With Nonsmall Cell Lung Cancer ≤2 cm

Front Surg. 2021 Oct 25:8:721567. doi: 10.3389/fsurg.2021.721567. eCollection 2021.

Authors

Bo Hao¹, Tao Fan¹, Juan Xiong¹, Lin Zhang¹, Zilong Lu¹, Bohao Liu¹, Heng Meng¹, Ruyuan He¹, Ning Li¹, Qing Geng¹

Affiliation

¹ Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, China.

Abstract

Background: Few studies attempt to investigate the impact of histology on the outcome of nonsmall-cell lung cancer (NSCLC) patients. In this study, we aim to determine whether the type of histology influenced the outcome of stage IA NSCLC patients with tumor size (TS) ≤20 mm. Methods: The data of the population in our study was collected from the Surveillance, Epidemiology, and End Results (SEER) program, which is supported by the National Cancer Institute of the United States. The primary outcome was overall survival (OS). Cox-regression proportional hazards models were performed to identify prognostic factors for OS. The secondary outcome was lung cancer-specific mortality (LCSM). A competing risk model was used to identify risk factors associated with LCSM. Results: A total of 4,424 eligible patients (T1a-bN0M0) who received sublobar resection [wedge resection (WR) and segmentectomy] were identified and included in the study for further analysis. For patients with TS ≤ 10 mm, multivariate Cox-regression analyses for OS showed that lung squamous cell carcinoma (LUSC) yielded poorer OS compared with lung adenocarcinoma (LUAD), and no difference was observed between LUSC and LUAD for LCSM in competing risk models. For patients with TS > 10 and ≤20 mm, multivariate analyses revealed that LUSC patients experienced poorer OS compared with that of LUAD; the univariate competing risk analysis indicated SCC pathology predicted an increased risk of death from lung cancer, whereas no difference is observed in the multivariate competing analysis. In addition, segmentectomy was associated with longer OS in patients with >10 and ≤20 mm but not in patients with ≤10 mm compared with WR. Conclusion: Our study demonstrated that squamous pathology was associated with the worse OS but not LCSM for patients with ≤20 mm compared with adenocarcinoma. Moreover, segmentectomy when compared to wedge resection appears to be associated with a better prognosis in patients with neoplasm >10 mm, but not in the case of nodule ≤10 mm.

Keywords: histology; lung adenocarcinoma; lung cancer-specific mortality; lung squamous cell carcinoma; overall survival.